NCT05240274View on ClinicalTrials.gov

The POWERED Study: Prophylaxis With Metformin to Prevent PTDM

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 25, 2019

Primary Completion Date

May 30, 2022

Study Completion Date

August 30, 2022

Conditions
Post-transplant Diabetes MellitusNew Onset Diabetes After TransplantNew Onset Diabetes After TransplantationKidney Transplant; ComplicationsRenal TransplantationEnd Stage Renal DiseaseMetformin
Interventions
DRUG

Metformin

metformin 500mg OD for 3 months to start within 10 days post-renal transplant

DRUG

Placebo

placebo 500mg OD for 3 months to start within 10 days post-renal transplant

Trial Locations (1)

E1 1BB

Royal London Hospital, Barts Health NHS Trust, London

All Listed Sponsors
lead

Barts & The London NHS Trust

OTHER

NCT05240274 - The POWERED Study: Prophylaxis With Metformin to Prevent PTDM | Biotech Hunter | Biotech Hunter